Rheumatoid Factor. Association with markers of atherogenic risk

Autoimmune diseases face a chronic inflammatory challenge with systemic repercussions. One of these problems is carciovascular pathology with early onset in relation to the rest of the population not affected by these conditions. Therefore, the possible prediction of cardiovascular risk based on more specific variables of these disorders constitutes an indisputable support tool for clinical practice in this type of patient. The present work is evidence in this direction for patients with rheumatoid arthritis.